In 1983 Wagner et al reported increased urinary nitrates in rats injected with endotoxin.' During the next decade endogenously produced nitric oxide (NO) was identified as the source of this increase in nitrate and as an important effector molecule in proinflammatory conditions such as sepsis.2 Serum nitrite and nitrate, the stable oxidative end products of NO, have been reported in multiple animal and human studies as an indirect measure of in vivo whole body NO production.3457 We3 and other investigators45 have reported increased endogenous NO production in patients with the sepsis syndrome. These clinical studies are consistent with laboratory studies showing increased NO production in various mammalian cell types after stimulation with proinflammatory mediators.89 Immune stimulation, characterised by the elaboration of proinflammatory mediators, also occurs after solid organ transplantation, and during allograft rejection and infectious processes. Accordingly, increased NO production manifest as increased serum nitrite and nitrate levels is also likely to occur in these clinical conditions.'0 Increased serum nitrite and nitrate levels may also be expected in clinical states which are not classically associated with immune activation. For example patients experiencing hypotension during haemodialysis'l or chronic heart disease'2 have increased endogenous NO production. Administration of exogenous NO (either as inhaled NO or as intravenous NO donors) and decreased metabolism or elimination of serum nitrite and nitrate (at either the renal or hepatic level) are other potential causes of increased serum levels of these metabolites.
The development of a rapid microtitre plate technique to measure serum nitrite and nitrate levels allows for the potential use of these measurements as a clinical tool to evaluate endogenous NO production. Serum nitrites and nitrates are stable end products of NO production, not immediate indicators of NO production. In vitro studies show that nitrite and nitrate levels may not be detectable until 24 hours after immune stimulation and NO production.89 Accordingly, a clinical state associated with increased NO production may not show increased nitrite and nitrate levels if evaluated too early in its evolution. Therefore, questions regarding increased NO production in specific clinical states may be more accurately evaluated by measuring the maximum nitrite and nitrate level attained during the course of an illness.
University of Pittsburgh School of Medicine, Pittsburgh, Millipore suction tray. The cadmium lined wells were washed once with 50 gl of ammonium chloride borate buffer, and then an equal volume of the Griess reagent was added to each sample and the absorbance read at 550 nm using potassium nitrate as a standard.
Nitrite concentrations were low ( < 10 gM) in the samples relative to nitrate concentrations. Therefore, the combined nitrate plus nitrite concentration ( iM) was used for data analysis.
The results of the assay procedure were compared to results obtained using high performance liquid chromatography with a copper coated cadmium column as previously published. 
DATA ANALYSIS AND DESCRIPTION
The degree to which serum nitrite plus nitrate levels represent exogenously administered NO was evaluated in two ways: (1) linear regression analysis was performed using total dosage of nitroprusside plus glyceryl trinitrate (jg/kg/ min) as the independent variable and the change in serum nitrite plus nitrate level from baseline as the dependent variable, and (2) the maximum serum nitrite plus nitrate concentrations attained by children receiving exogenous NO were compared to that of the control group.
The degree to which serum nitrite plus nitrate concentrations represented increased endogenous NO production was evaluated by comparing the maximum level of serum nitrite plus nitrate reached by children during the course of (1) infection, (2) sepsis, (3) shock without sepsis, (4) transplantation, (5) transplantation with infection, (6) transplantation with sepsis, or (7) transplantation with rejection, to the maximum level attained by children in the control group. Because the data were not normally distributed, the Kruskal-Wallis test with Dunn' s test for multiple comparisons was used and a p value < 0.05 was considered significant. Distributions of the maximum serum nitrite plus nitrate levels attained by patients in the various study groups are further described in histogram formats.
The value of the serum nitrite and nitrate concentration as an indicator of disease was assessed by comparing the levels at the time of diagnosis among the different groups using the Kruskal-Wallis test with Dunn's test for multiple comparisons. A p value of < 0.05 was considered significant. For any group with a p < 0.05 at the time of diagnosis, the sensitivity, specificity, positive predictive value, and negative predictive value of the serum nitrite plus nitrate level as an indicator of the disease state was calculated at the threshold levels of 2 to 5 standard deviations (SD) above the respective mean for the control group.
The degree to which differences in renal or hepatic metabolism affected serum levels of nitrite plus nitrate was evaluated as follows. The effect of renal dysfunction was evaluated in patients who showed a doubling of serum creatinine in at least three consecutive serum samples and who had concomitant measurements of nitrite and nitrate levels. Individual linear regression analyses were performed using serum creatinine as the independent variable and serum levels of nitrite plus nitrate as the dependent variable. Renal dysfunction was also analysed by performing linear regression analysis using first day values of serum creatinine and concomitant serum concentrations of nitrite plus nitrate for each patient. The effect of hepatic dysfunction on serum concentrations of nitrite and nitrate was examined in patients having at least three serum bilirubin measurements with concomitant measurements of nitrite and nitrate and no evidence of haemolysis. For each of these patients, linear correlation analysis was carried out using serum bilirubin levels as the independent variable and serum concentrations of nitrite plus nitrate as the dependent variable.
Examples of individual patients showing daily changes in clinical status and the associated changes in total serum nitrite plus nitrate are given as well.
Results
One hundred and thirty seven consecutive critically ill children were evaluated. Thirteen children met criteria for more than one of the study groups at the time the maximum serum nitrite and nitrate concentration was attained and were therefore excluded from analysis. Therefore 124 children meeting criteria for only one group at the time of diagnosis and at the point of maximum serum nitrite plus nitrate concentration were included in the analysis. The control group reflected the diversity of the patient population typically seen in our intensive care unit. Postoperative diagnoses included intracranial and spinal surgery (n = 13), head and neck surgery (n = 4), and cardiac surgery (n = 13 (fig 3) . However, all three patients with acute rejection attained a maximum concentration greater than 100 pM.
Among non-transplant patients, only patients with sepsis syndrome had higher serum nitrite plus nitrate than controls at the time of diagnosis. Based on this analysis the sensitivity, specificity, positive predictive value, and negative predictive value of serum nitrite plus nitrate concentrations at the time of diagnosis of sepsis was evaluated at 2, 3, 4, and 5 SD above the respective mean for the control group (table 3). All patients from the control, infection, sepsis, and sepsis without shock groups were included in this evaluation. No patients with transplantation were included. Notably, a serum level of 35.8 jiM (2 SD above the control mean) had a negative predictive value of 99% for sepsis with a sensitivity of 92% and a specificity of 86%. In contrast, a serum concentration of 63.6 jM (5 SD from the control mean) had a positive predictive value of 100% for sepsis with a sensitivity of 50% and a specificity of 100%.
Eighteen children showed a doubling of serum creatinine with at least three concomi- Figure 4B shows a child with septic shock that was associated with increasing serum nitrite plus nitrate concentrations. Figure 4C shows a child with acute allograft rejection who showed an increase in serum nitrite plus nitrate concentrations during the episode of rejection. The values decreased after immunosuppressive treatment with OKT-3. Figure 4D represents paediatric population. As hypothesised, patients receiving exogenous sources of NO (glyceryl trinitrate, nitroprusside, or inhaled NO) had higher levels than control patients. The observed correlation between dosage changes in NO donor medications and serum nitrite plus nitrate concentrations suggests that this test may be a useful indirect measure of NO in children.
As hypothesised, serum nitrite plus nitrate concentrations were increased in children with sepsis or transplantation at the time of diagnosis. Interestingly, significantly increased values were not seen in children with infection, or shock without sepsis, two groups expected to have increased endogenous NO production relative to control patients at the time of diagnosis. However, over the course of illness both groups reached a maximum level greater than that of the control population. Similar results occurred in the transplant population. At the time of diagnosis, children with transplantation having concomitant sepsis or rejection did not have significantly higher concentrations than transplant patients without sepsis or rejection. However, over time the maximum concentration attained was higher when sepsis or rejection was present concomitantly. One possible explanation for these findings is that NO production may increase at the onset of these conditions, but increased serum nitrite plus nitrate levels are not detectable for some period of time.
The lack of a strong association between evolving renal or hepatic dysfunction and serum nitrite plus nitrate concentrations supports the notion that increased concentrations during infection, sepsis, shock without sepsis, transplantation, or rejection are due, at least in part, to increased endogenous NO production rather than to decreased metabolism or elimination of stable end products. This assertion must be considered carefully because differences in metabolism could be important in individual patients.
Endogenous NO production occurs through the enzyme nitric oxide synthase (NOS), of which there are three isoforms: endothelial NOS, neuronal NOS, and inducible NOS (iNOS).'5 iNOS is expressed after exposure to endotoxin or cytokines, or both, and is thought to be responsible for prolonged and high output of NO seen during proinflammatory conditions such as the sepsis syndrome.'6 Animal and human studies have shown that increased serum nitrite and nitrate concentrations reflect increased endogenous production of NO during the sepsis syndrome.' 4 Interestingly, iNOS regulation can manifest marked species variability and specificity, implying that iNOS regulation in humans may not be governed by the same proinflammatory mediators that lead to iNOS expression in rodents and other mammalian species."7 Our present data indicate that increased endogenous production of NO occurs not only during the sep- sis syndrome, but also in other clinical conditions associated with immune activation such as infection, transplantation, and rejection. The NOS isoform responsible for this increased endogenous NO remains to be definitively established.
Patients with infection tended to have lower serum levels of nitrite and nitrate than patients with the sepsis syndrome. We speculate that some patients with a focus of infection who go on to develop the sepsis syndrome may have a more extensive elaboration ofproinflammatory mediators and consequently produce greater amounts of NO (possibly through iNOS) than patients with infection who do not develop the sepsis syndrome. If this speculation is correct, then it would lend further support for the role of NO as an important effector molecule in the manifestations of the sepsis syndrome.
The observation that patients with either transplantation or rejection had increased serum nitrite plus nitrate concentrations provides a relevant clinical correlate to rodent models of transplantation. '8 19 In these models serum nitrite and nitrate concentrations increase in proportion to the degree of rejection, suggesting that greater immune stimulation (as occurs during acute allograft rejection) leads to greater endogenous NO production. A similar phenomenon may have occurred in our patients, as evidenced by the maximum serum nitrite plus nitrate values greater than 100 iM in all three patients with acute rejection but in only one of seven patients with transplantation in the absence of acute rejection.
We also observed higher maximum serum nitrite plus nitrate concentrations in children who developed shock as a result of chronic heart failure, haemorrhage, or cardiorespiratory arrest. These conditions are not commonly linked to inflammation, and are not generally thought to be associated with increased iNOS expression. Rather, the endothelial NOS pathways have been hypothesised as the source of increased NO production. Interestingly, patients with sepsis had higher serum nitrite plus nitrate concentrations than children with shock not associated with sepsis. One possible explanation for this observation is that immune activation increases NO production in children with sepsis in addition to any increase in NO which might be associated with hypotension per se. Future studies will be needed to address this possibility. The clinical value of serum nitrite and nitrate concentrations as a tool for diagnosis or therapeutic monitoring of sepsis or allograft rejection requires further study. The observation that serum nitrite plus nitrate concentrations above 80 jM were attained only by children with sepsis, transplantation, or organ rejection suggests that a threshold serum nitrite plus nitrate concentration may be used as an indicator of immune stimulation and increased endogenous NO production. The observation that individual patients had increased levels above 80 jM when rejection or sepsis occurred, and returned to lower levels when sepsis or rejection resolved, suggests that absolute changes in serum nitrite and nitrate concentrations could be indicative of these disease states. In some children, it may be possible to follow concentrations as a measure of therapeutic efficacy. However, the observation that some children with sepsis never attain concentrations greater than those in control patients suggests that this test alone will not be diagnostic in all children with sepsis. Also the observation that the level at presentation with sepsis can be lower than the maximum value attained over time suggests that the diagnostic value of the test will depend on the time when the assay is performed. Similarly, the overlap between the maximum serum nitrite plus nitrate concentrations attained by transplantation patients, with and without acute allograft rejection, suggests that this test will be unable to differentiate all acute rejection events. At present no laboratory test other than biopsy has been shown to possess this degree of discrimination. Future investigation is warranted to determine whether serum nitrite and nitrate concentrations can add any further predictive power to tests currently used to evaluate children at risk for sepsis or rejection.
Limitations of this study should be considered. Definitions of sepsis and rejection may be subject to interpretation. For example, we did not subcategorise children with the systemic inflammatory response syndrome.20 Some patients in the infection group may have been classified as having the systemic inflammatory response syndrome, rather than infection, by other investigators. Also, we did not require biopsy verification of acute rejection. Some patients with transplantation may have had varying degrees of acute rejection, but according to our definitions were placed in the transplantation group rather than the rejection group. Third, increased levels in patients with acute rejection may have occurred secondary to immunotherapy rather than the rejection process alone.
In summary, we suggest that endogenous NO production can be evaluated in critically ill children using a method for measurement of nitrite and nitrate which allows for rapid processing of samples in the clinical laboratory setting. It is important to note that measurement of nitrite levels alone would not have been sufficient to carry out this study; it was necessary to develop a technique that allows for concomitant measurement of nitrate as well. The pending development of pharmacological strategies directed towards the selective inhibition of iNOS underlines the relevance of these data. We conclude that endogenous NO production, as measured by serum nitrite and nitrate levels, is increased in clinical conditions characterised by immune stimulation: infection, sepsis, transplantation, and rejection, and in a clinical condition not commonly associated with immune activation-shock without sepsis. Our data provide a foundation for future studies concerning the role and sources of endogenous NO production in pediatric critical illness. The value of serum nitrite and nitrate concentrations as a useful diagnostic tool or therapeutic monitor in the clinical evaluation of children at risk for developing the
